Oligonucleotides as modulators of cancer gene expression

Pharmacology and Therapeutics

Volumn 74, Issue 3, 1997, Pages 317-332

  Curcio, Lisa D ^a   Bouffard, David Y ^b   Scanlon, Kevin J ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b BAYER AG   (Germany)

Author keywords

Antisense; Cancer; Oligonucleotide; Review; Ribozyme; Triplex

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PLATELET DERIVED GROWTH FACTOR B; PLEIOTROPHIN; RIBOZYME;

CHEMICAL STRUCTURE; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; MUTATION; ONCOGENE; ONCOGENE C MYC; ONCOGENE NEU; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; RNA TRANSLATION;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; RNA, CATALYTIC;

EID: 0030881290     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00005-3     Document Type: Review

References (157)

1. Agris, C. H., Blake, K. R., Miller, P. S., Reddy, M. P. and Ts'o, P. O. P. (1986) Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates. Biochemistry 25: 6268-6275.
2. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N. and Perucho, M. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554.
3. Bass, B. L. and Weintraub, H. (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 31: 1089-1098.
4. Bertrand, E., Pictet, R. and Grange, T. (1994) Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucl. Acids Res. 22: 293-300.
5. Boiziau, C., Kufurst, R., Cazenave, C., Roig, V., Thuong, N. T. and Toulme, J.-J. (1991) Inhibition of translation by antisense oligonucleotides via an RNase-H independent mechanism. Nucl. Acids Res. 19: 1113-1119.
6. Bos, J. L. (1989) ras Oncogene in human cancer: a review. Cancer Res. 49: 4682-4689.
7. Bouffard, D. Y., Ohkawa, T., Kijima, H., Irie, A., Suzuki, T., Curcio, L. D., Holm, P. S., Sassani, A. and Scanlon, K. J. (1996) Oligonucleotide modulation of MDR resistance. Eur. J. Cancer: 32A: 1010-1018.
8. Buzayan, J. M., Feldstein, P. A., Bruening, G. and Eckstein, F. (1988) RNA mediated formation of a phosphorothioate diester bond. Biochem. Biophys. Res. Commun. 156: 340-347.
9. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. (1991) Oncogenes and signal transduction. Cell 64: 281-302.
10. Cech, T. R., Zaug, A. J. and Grabowski, P. J. (1981) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27: 487-496.
11. Cherny, D. Y., Belotserkovskii, B. P., Frank-Kamenetskii, M. D., Egholm, M., Buchardt, O., Berg, R. H. and Nielsen, P. E. (1993) DNA unwinding upon strand-displacement binding of a thymine substituted polyamide to double-stranded DNA. Proc. Natl. Acad. Sci. USA 90: 1667-1670.
12. Citro, G., Perotti, D., Cuci, C., D'Agnano, I., Sacchi, A., Zupi, G. and Calabretta, B. (1992) Inhibition of leukemic cell proliferation by receptor-mediated uptake of c-myb antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 89: 7031-7035.
13. Cooney, M., Czernuszewicz, G., Postel, E. H., Flint, S. J. and Hogan, M. E. (1988) Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 241: 456-459.
14. Crooke, R. M. (1991) In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anticancer Drug Des. 6: 609-646.
15. Crooke, S. T. (1992) Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32: 329-376.
16. Crooke, S. T. (1993) Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7: 533-539.
17. Czubayko, F., Riegel, A. T. and Wellstein, A. (1994) Ribozyme-targeting elucidates a direct role of pleiotropin in tumor growth. J. Biol. Chem. 269: 21358-21363.
18. Demidov, V., Frank-Kamentskii, M. D., Egholm, M., Buchardt, O. and Nielson, P. E. (1993) Sequence selective double strand DNA cleavage by peptide nucleic acid (PNA) targeting using nuclease S1. Nucl. Acids Res. 21: 2103-2107.
19. Dorai, T., Kobayashi, H., Holland, J. F. and Ohnuma, T. (1994) Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. Mol. Pharmacol. 46: 437-444.
20. Ebbinghaus, S. W., Gee, J. E., Rodu, B., Mayfield, C. A., Sanders, G. and Miller, D. M. (1993) Triplex formation inhibits HER-2/neu transcription in vitro. J. Clin. Invest. 92: 2433-2439.
21. Egan, S. E. and Weinberg, R. A. (1993) The pathway to signal achievement. Nature 365: 781-783.
22. Endicott, J. A. and Ling, V. (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem. 58:131-171.
23. Feldstein, P. A., Buzayan, J. M. and Bruening, G. (1989) Two sequences participating in the autolytic processing of satellite tobacco ringspot virus complementary RNA. Gene 82: 53-61.
24. Felsenfeld, G. and Rich, A. (1957) Studies on the formation of two- and three-stranded polyribonucleotides. Biochem. Biophys. Acta 26: 457-468.
25. Felsenfeld, G., Davies, D. R. and Rich, A. (1957) Formation of a three-stranded polynucleotide molecule. J. Am. Chem. Soc. 79: 2023-2024.
26. Feng, M., Cabrera, G., Deshane, J., Scanlon, K. J. and Curiel, D. T. (1995) Neoplastic reversion accomplished by high efficiency adenoviral mediated delivery of anti-ras ribozymes. Cancer Res. 55: 2024-2028.
27. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M. and Pastan, I. (1987) Expression of multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84: 265-269.
28. Ford, J. M. and Hait, W. N. (1993) Pharmacologic circumvention of multidrug resistance. Cytotechnology 12: 171-212.
29. Francois, J.-C., Saison-Behmoaras, T., Barbier, C., Chassignal, M., Thuong, N. T. and Hélène, C. (1989) Sequence-specific recognition of duplex DNA via triple-helix formation for oligonucleotides covalently linked to a phenanthroline-copper chelate. Proc. Natl. Acad. Sci. USA 87: 9858-9862.
30. Frank-Kamentskii, M. D. and Mirkin, S. M. (1995) Triplex DNA structures. Annu. Rev. Biochem. 64: 65-95.
31. Funato, T., Shitara, T., Tone, T., Jiao, L., Kashani-Sabet, M. and Scanlon, K. J. (1994) Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme. Biochem. Pharmacol. 48: 1471-1475.
32. Gee, J. E, Blume, S., Snyder, R. C., Ray, R. and Miller, D. M. (1992) Triplex formation prevents Sp1 binding to the dihydrofolate reductase promoter. J. Biol. Chem. 267: 11163-11167.
33. Georges, R. N., Mukhopadhyay, T., Zhang, Y., Yen, N. and Roth, J. A. (1993) Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res. 53: 1743-1746.
34. Gewirtz, A. M. and Calabretta, B. (1988) A c-myb antisense oligonucleotide inhibits normal human hematopoiesis in vitro. Science 242: 1303-1306.
35. Goodchild, J., Agrawal, S., Civeira, M. P., Sarin, P. S., Sun, D. and Zamecnik, P. C. (1988) Inhibition of human immunodeficiency virus replication by anti-sense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA 85: 5507-5511.
36. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427.
37. Gros, P., Croop, J., Roninson, I., Varshavsky, A. and Housman, D. E. (1986) Isolation and characterization of DNA sequences amplified in multidrug resistant hamster cells. Proc. Natl. Acad. Sci. USA 83: 337-341.
38. Grunewald, K., Lyons, J., Frohlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. and Bartram, C. R. (1989) High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int. J. Cancer 43: 1037-1041.
39. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35: 849-857.
40. Gunning, P., Leavitt, J., Muscat, G., Ng, S. and Kedes, L. (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84: 4831-4835.
41. Hampel, A. and Tritz, R. (1989) RNA catalytic properties of the minimum (-)sTRSV sequence. Biochemistry 28: 4929-4933.
42. Hampel, A., Tritz, R., Hicks, M. and Cruz, P. (1990) "Hairpin" catalytic RNA model: evidence for helices and sequence requirement for substrate RNA. Nucl. Acids Res. 18: 299-304.
43. Hampel, K. J., Crosson, P. and Lee, J. S. (1991) Polyamines favor DNA triplex formation at neutral pH. Biochemistry 30: 4455-4459.
44. Hampel, K. J., Burkholder, G. D. and Lee, J. S. (1993) Plasmid dimerization mediated by triplex formation between polypyrimidine-polypurine repeats. Biochemistry 32: 1072-1077.
45. He, Y.-K., Lu, C. D. and Qi, G. (1993) In vitro cleavage of HPV16 E6 and E7 RNA fragments by synthetic ribozymes and transcribed ribozymes from RNA-trimming plasmids. FEBS Lett. 322: 21-24.
46. Hélène, C. (1991) Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur. J. Cancer 27: 1466-1471.
47. Helm, C. W., Shrestha, K., Thomas, S., Shingleton, H. M. and Miller, D. M. (1993) A unique c-myc-targeted triplex-forming oligonucleotide inhibits the growth of ovarian and cervical carcinomas in vitro. Gynecol. Oncol. 49: 339-343.
48. Herschlag, D. (1991) Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better. Proc. Natl. Acad. Sci. USA 88: 6921-6925.
49. Hijiya, N., Zhang, J., Ratajczak, M. Z., Kant, J. A., DeRiel, K., Herlyn, M., Zon, G. and Gewirtz, A. (1994) Biological and therapeutic significance of MYB expression in human melanoma. Proc. Natl. Acad. Sci. USA 91: 4499-4503.
50. Holm, P. S., Scanlon, K. J. and Dietel, M. (1994) Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Br. J. Cancer 70: 239-243.
51. Holm, P. S., Dietel, M. and Krupp, G. (1996) Similar cleavage efficiencies of an oligoribonucleotide substrate and an mdr1 mRNA segment by a hammerhead ribozyme. Gene 167: 221-225.
52. Hunter, T. (1991) Cooperation between oncogenes. Cell 64: 249-270.
53. Inouye, M. (1988) Antisense RNA: its functions and applications in gene regulation-a review. Gene 72: 25-34.
54. Izant, J. G. and Weintraub, H. (1984) Inhibition of thymidine kinase gene expression by antisense RNA: a molecular approach to genetic analysis. Cell 36: 1007-1010.
55. Jayasena, S. D. and Johnston, B. H. (1992) Oligonucleotide-directed triple helix formation at adjacent oligopurine and oligopyrimidine DNA tracts by alternate strand recognition. Nucl. Acids Res. 20: 5279-5288.
56. Jetter, M. C. and Hobbs, F. W. (1993) 7,8-Dihydro-8-oxoademne as a replacement for cytosine in the third strand of triple helices. Triplex formation without hypochromicity. Biochemistry 32: 3249-3254.
57. n: chemical evidence for a three-stranded structure in plasmids. Science 241: 1800-1804.
58. Juliano, R. L. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem. Biophys. Acta 455: 152-162.
59. Kartner, N., Riordan, J. R. and Ling, V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288.
60. Kartner, N., Evernden-Porelle, D., Bradley, G. and Ling, V. (1985) Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature (London) 316: 820-823.
61. Kashani-Sabet, M., Funato, T., Tone, T., Jiao, L., Wang, W., Yoshida, E., Kashfian, B. I., Shitara, T., Wu, A. M., Moreno, J. G., Traweek, S. T., Ahlering, T. E. and Scanlon, K. J. (1992) Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res. Dev. 2: 3-15.
62. Kashani-Sabet, M, Funato, T., Florenes, V. A., Fodstad, O. and Scanlon, K. J. (1994) Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res. 54: 900-902.
63. Kessler, D. J., Pettit, B. M., Cheng, Y.-K., Smith, S. R., Jayaraman, K., Vu, H. M. and Hogan, M. E. (1993) Triple helix formation at distant sites: hybrid oligonucleotides containing a polymeric linker. Nucl. Acids Res. 21: 4810-4815.
64. Kiehntopf, M., Brach, M. A., Licht, T., Petschauer, S., Karawajew, L., Kirschning, C. and Hermann, F. (1994) Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13: 4645-4652.
65. Kijima, H., Ishida, H., Ohkawa, T., Kashani-Sabet, M. and Scanlon, K. J. (1995) Therapeutic application of ribozymes. Pharmacol. Ther. 68: 247-267.
66. Kijima, H., Bouffard, D. Y. and Scanlon, K. J. (1996) Ribozyme-mediated reversal of human pancreatic carcinoma phenotype. In: Bone Marrow Transplantation-Basic and Clinical Studies, pp. 153-163, Ikehara, S., Takaku, F. and Good, R. A. (eds.) Springer-Verlag, Tokyo.
67. Kobayashi, H., Dorai, T., Holland, J. F. and Ohnuma, T. (1994) Reversal of drug sensitivity in multidrug-resistant tumor cells by MDR-1 (PGY-1) ribozyme. Cancer Res. 54: 1271-1275.
68. Koh, J. S. and Dervan, P. B. (1992) Design of a non natural deoxyribonucleoside for recognition of GC base pairs by oligonucleotide-directed triple helix formation. J. Am. Chem. Soc. 114: 1470-1478.
69. Koizumi, M., Hayase, Y., Iwai, S., Kamiya, H., Inoue, H. and Ohtsuka, E. (1989) Design of RNA enzymes distinguishing a single base mutation in RNA. Nucl. Acids Res. 17: 7059-7071.
70. Koizumi, M., Kamiya, H. and Ohtsuka, E. (1992) Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene. Gene 117: 179-184.
71. Koob, M., Grimes, E. and Szybalski, W. (1988) Conferring operator specificity on restriction endonucleases. Science 241: 1084-1086.
72. 3-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range. Proc. Natl. Acad. Sci. USA 89: 3761-3764.
73. Kruger, K., Grabowski, P. J., Zaug, A. J., Sands, J., Gottschling, D. E. and Cech, T. R. (1982) Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31: 147-157.
74. Kumar, P. K. R. and Ellington, A. D. (1995) Artificial evolution and natural ribozymes. FASEB J. 9: 1183-1195.
75. Kumar, P. K. R., Taira, K. and Nishikawa, S. (1994) Chemical probing studies of variants of the genomic hepatitis delta virus ribozyme by primer extension analysis. Biochemistry 33: 583-592.
76. Kurzock, R., Gutterman, J. U. and Talpaz, M. (1988) The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 319:990-998.
77. Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H. and Laimins, L. A. (1992) Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11: 3045-3052.
78. Le Doan, T., Perrouault, L., Praseuth, D., Habhoub, N., Decout, J. L., Thoung, T., Lhomme, J. and Hélène, C. (1987) Sequence-specific recognition photo crosslinking and cleavage of the DNA double helix by an oligo-[alpha]- thymidylate covalently linked to an azidoproflavine derivatives. Nucl. Acids Res. 15: 7749-7760.
79. Lee, J. S., Johnson, D. A. and Morgan, A. R. (1979) Complexes formed by (pyrimidine)n . (purine)n DNAs on lowering the pH are three stranded. Nucl. Acids Res. 6: 3073-3091.
80. Lee, J. S., Woodsworth, M. L., Latimer, L. J. and Moran, J. R. (1984) Poly(pyrimidine)·- poly(purine) synthetic DNAs containing 5-methylcytosine form stable triplexes at neutral pH. Nucl. Acids Res. 12: 6603-6614.
81. Lemaitre, M., Bayard, B. and Lebleu, B. (1987) Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA 84: 648-652.
82. Leonetti, J. P., Machy, P., Degols, G., Lebleu, B. and Leserman, L. (1990) Antibody-targeted liposomes containing oligodeoxynucleotides complementary to viral RNA selectively inhibits viral replication. Proc. Natl. Acad. Sci. USA 87: 2448-2451.
83. Leonetti, J. P., Degols, C., Clarenc, J. P., Mechti, N. and Lebleu, B. (1993) Cell delivery and mechanism of action of anti-sense oligonucleotides. Prog. Nucl. Acid Res. Mol. Biol. 44: 143-166.
84. Leopold, L. H., Shore, S. K., Newkirk, T. A., Reddy, R. M. V. and Reddy, E. P. (1995) Multi-unit ribozyme mediated cleavage of bcr-abl mRNA in myeloid leukemias. Blood 85: 2162-2170.
85. Letai, A. G., Palladino, M. A., Fromm, E., Rizzo, V. and Fresco, J. R. (1988) Specificity in formation triple-stranded nucleic acid helical complexes: studies with agarose-linked poly-ribonucleotide affinity columns. Biochemistry 28: 9108-9112.
86. Lisziewicz, J., Sun, D., Metelev, V., Zamecnik, P., Gallo, R. C. and Agrawal, S. (1993) Long-term treatment of human immunodeficiency virus-infected cells with anti-sense oligonucleotide phosphorothioates. Proc. Natl. Acad. Sci. USA 90: 3860-3864.
87. Lowy, D. R., Kirnbauer, R. and Schiller, J. T. (1994) Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA 91:2436-2440.
88. Lu, C. D., Chatterjee, S., Brar, D. and Wong, K. K., Jr. (1994) Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16. Cancer Gene Ther. 1: 267-277.
89. Lu, X.-M., Fischman, A. J., Jyawook, S. L., Hendricks, K., Tompkins, R. G. and Yarmusch, M. L. (1994) Antisense DNA delivery in vivo: liver targeting by receptor-mediated uptake. J. Nucl. Med. 35: 269-275.
90. Lyamichev, V. I., Mirkin, S. M. and Frank-Kamenetskii, M. D. (1986) Structure of homopurine-homopyrimidine trait in superhelical DNA. J. Biomol. Struct. Dyn. 3: 667-669.
91. Lyamichev, V. I., Mirkin, S. M., Frank-Kamenetskii, M. D. and Cantor, C. R. (1988) A stable complex between homopyrimidine oligomers and the homologous regions of duplex DNAs. Nucl. Acids Res. 16: 2165-2178.
92. Maher, L. J., Wold, B. and Dervan, P. B. (1989) Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245: 725-730.
93. Maher, L. J., Dervan, P. B. and Wold, B. (1992) Analysis of promoter-specific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system. Biochemistry 31: 70-81.
94. Matsushita, H., Kobayashi, H., Mori, S., Kizaki, M. and Ikeda, Y. (1995) Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21). Biochem. Biophys. Res. Commun. 215: 431-437.
95. Mayfield, C., Ebbinghaus, S., Gee, J., Jones, D., Rodu, B., Squibb, M. and Miller, D. (1994) Triplex formation by the human Haras promoter inhibits Sp1 binding and in vitro transcription. J. Biol. Chem. 269: 18232-18238.
96. McManaway, M. E., Neckers, L. M., Loke, S. L., Al-Nasser, A. A., Redner, R. L., Shiramizu, B. T., Goldschmidts, W. L., Huber, B. E., Bhatia, K. and Magrath, I. T. (1990) Tumor-specific inhibition of lymphoma growth by an anti-sense oligodeoxynucleotide. Lancet 335: 808-811.
97. McShan, W. M., Rossen, R. D., Laughter, A. H., Trial, J., Kessler, D. J., Zendegui, J. G., Hogan, M. E. and Orson, F. M. (1992) Inhibition of transcription of HIV-1 in infected human cells by oligonucleotides designed to form DNA triple helices. J. Biol. Chem. 267: 5712-5721.
98. Melton, D. A. (1985) Injected antisense RNAs specifically block messenger RNA translation in vivo. Proc. Natl. Acad. Sci. USA 82: 144-148.
99. Mergny, J.-L., Sun, J.-S., Rougee, M., Montenay-Garesteir, T., Barcelo, F., Chomilier, J. and Hélène, C. (1991) Sequence specificity on triple-helix formation: experimental and theoretical studies of the effect of mismatches on triplex stability. Biochemistry 30: 9791-9798.
100. Mirkin, S. M., Lyamichev, V. I., Drushlyak, K. N., Dobrynin, V. N., Filippov, S. A. and Frank-Kamenetskii, M. D. (1987) DNA H form requires a homopurine-homopyrimidine mirror repeat. Nature 330: 495-497.
101. Morgan, A. R. and Wells, R. D. (1968) Specificity of the three-stranded complex formation between double-stranded DNA and single-stranded RNA containing repeating nucleotide sequences. J. Mol. Biol. 37: 63-80.
102. Moser, H. E. and Dervan, P. B. (1987) Sequence-specific cleavage of double helical DNA by triple helix formation. Science 238: 645-650.
103. Mouscadet, J. F., Ketterlé, C., Goulaouic, H., Carteau, S., Subra, F., Le Bref, M. and Auclair, C. (1994) Triple helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence. Biochemistry 33: 4187-4196.
104. Mukhopadhyay, T., Tansky, M., Cavender, A. and Roth, J. A. (1991) Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res. 51: 1744-1748.
105. Neckers, L., Whitsell, L., Rosolen, A. and Geselwitz, D. A. (1992) Antisense inhibition of oncogene expression. Crit. Rev. Oncog. 3: 175-231.
106. Ohkawa, J., Koguma, T., Okhda, T. and Taira, K. (1995) Ribozyme: from mechanistic studies to applications in vivo. J. Biochem. 118: 251-258.
107. Ohta, Y., Tone, T., Shitara, T., Funato, T., Jiao, L., Kashfian, B. I., Yoshida, E., Horng, M., Tsai, P., Lauterbach, K., Kashani-Sabet, M., Florenes, V. A., Fodstad, O. and Scanlon, K. J. (1994) H-ras ribozyme mediated alteration of the human melanoma phenotype. Annu. Rev. NY Acad. Sci. 716: 242-253.
108. Ohta, Y., Kijima, H., Kashani-Sabet, M. and Scanlon, K. J. (1996a) Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucl. Acids Res. 24: 938-942.
109. Ohta, Y., Kijima, H., Kashani-Sabet, M. and Scanlon, K. J. (1996b) Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymes. J. Invest. Dermatol. 106: 275-280.
110. Ono, A., Ts'o, P. O. P. and Kan, L.-S. (1991) Triplex formation of oligonucleotides containing 2′-O-methylpseudoisocytidine in substitution for 2′-deoxycytidine. Am. Chem. Soc. 113: 4032-4033.
111. Orson, F. M., Thomas, D. W., McShan, W. M., Kessler, D. J. and Hogan, M. E. (1991) Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region colinear triplex formation in lymphocytes. Nucl. Acids Res. 19: 3435-3441.
112. Orson, F. M., Kinsey, B. M. and McShan, W. M. (1994) Linkage structures strongly influence the binding cooperativity of DNA intercalators conjugated to triplex forming oligonucleotides. Nucl. Acids Res. 22: 479-484.
113. Pachuk, C. J., Yoon, K., Moelling, K. and Coney, L. R. (1993) Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to noncontinuous sequences. Nucl. Acids Res. 22: 301-307.
114. Perotta, A. T. and Been, M. D. (1992) Cleavage of oligoribonucleotides by a ribozyme derived from the hepatitis virus RNA sequence. Biochemistry 31: 16-21.
115. Perroualt, L., Asseline, U., Rivalle, C., Thuong, N. T., Bisagni, E., Giovannangeli, G., Le Doan, T. and Hélène, C. (1990) Sequence-specific artificial photo-induced endonucleases based on triple helix forming oligonucleotides. Nature 344: 450-460.
116. Pie, D., Corey, D. R. and Schultz, P. C. (1990) Site-specific cleavage of duplex DNA by a semi-synthetic nuclease via triple-helix formation. Proc. Natl. Acad. Sci. USA 86: 9702-9706.
117. Plum, G. E., Park, Y.-W., Singleton, S. F., Dervan, P. B. and Breslauer, K. J. (1990) Thermodynamic characterization of the stability and the melting behavior of a DNA triplex: a spectroscopic and calorimetric study. Proc. Natl. Acad. Sci. USA 87: 9436-9440.
118. Postel, E. H., Flint, S. J., Kessler, D. J. and Hogan, M. E. (1991) Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc. Natl. Acad. Sci. USA 88: 8227-8231.
119. Povsic, T. J., Strobel, S. J. and Dervan, P. B. (1992) Sequence-specific double strand alkylation and cleavage of DNA mediated by triple-helix formation. J. Am. Chem. Soc. 114: 5934-5941.
120. Riley, M., Maling, B. and Chamberlin, M. J. (1966) Physical and chemical characterization of two- and three-stranded adeninethymine and adenine-uracil homopolymer complexes. J. Mol. Biol. 20: 359-389.
121. Roberts, T. M. (1992) A signal chain of events. Nature 360: 534-535.
122. Roninson, I. B. (1991) Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press, New York.
123. Roninson, I. B., Chin, J. E., Choi, K., Gros, P., Housman, D. E., Fojo, A., Gottesman, M. M. and Pastan, I. (1986) Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc. Nad. Acad. Sci. USA 83: 4538-4542.
124. Rowley, J. D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine flourescence and giemsa staining. Nature (Lond.) 243: 290-293.
125. Scanlon, K. J., Ishida, H. and Kashani-Sabet, M. (1994) Ribozyme-mediated reversal of the multidrug-resistant phenotype. Proc. Natl. Acad. Sci. USA 91: 11123-11127.
126. Shore, S. K., Nabriss, P. M. and Reddy, E. P. (1993) Ribozyme-mediated cleavage of the BCR/ABL oncogene transcript; in vitro cleavage of RNA and in vivo loss of P210 protein kinase activity. Oncogene 8: 3183-3188.
127. Skorski, T., Nieborowska-Skorska, M., Nicolaides, N. C., Szczylik, C., Iverson, P., Iozza, R. V., Zon, G. and Calabretta, B. (1994) Suppression of Philadelphia leukemia cell growth in mice by BCR-ABL antisense oligonucleotide. Proc. Natl. Acad. Sci. USA 91: 4504-4508.
128. Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swiderski, P., Kaplan, B. E. and Forman, S. J. (1993) Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82: 600-605.
129. Stehelin, D., Varmus, H. E., Bishop, J. M. and Vogt, P. K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173.
130. Stein, C. A. and Cheng, Y.-C. (1993) Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261: 1004-1012.
131. Stein, C. A., Tonkinson, J. L., Zhang, L.-M., Yakubov, L., Gervasoni, J., Taub, R. and Rotenberg, S. A. (1993) Dynamics of internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32: 4855-4861.
132. Strobel, S. A. and Dervan, P. B. (1991) Single-site enzymatic cleavage of yeast genomic DNA mediated by triple-helix formation. Nature 350: 172-174.
133. Sun, J. S., Giovannangeli, C., Francois, J. C., Kurfurst, R., Montenay-Garestier, T., Asseline, U., Saison-Behmoaras, T., Thuong, N. T. and Hélène, C. (1991) Triple-helix formation by oligodeoxynucleotides and oligodeoxynucleotide-intercalator conjugates. Proc. Natl. Acad. Sci. USA 88: 6023-6027.
134. Symons, R. H. (1994) Ribozymes. Curr. Opin. Struct. Biol. 4: 322-330.
135. Szczylik, T., Skorski, T., Nicolaides, N. C., Manzella, L., Malaguarmera, L., Venturelli, D., Gewirtz, A. M. and Calabretta, B. (1991) Selective inhibition of leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotides. Science 253: 562-565.
136. Teeter, L. D., Eckersberg, T., Tsai, Y. and Kuo, M. T. (1991) Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgpl reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ. 2: 429-437.
137. Thill, G., Vasseur, M. and Tanner, N. K. (1993) Structural and sequence elements required for the self-cleaving activity of the hepatitis delta virus ribozyme. Biochemistry 32: 4254-4262.
138. Tone, T., Kashani-Sabet, M., Funato, T., Shitara, T., Yoshida, E., Kashfian, B. I., Horng, M., Fodstad, O. and Scanlon, K. J. (1993) Suppression of EJ cells tumorigenicity. In Vivo 7: 471-476.
139. Tuschl, T., Gohlke, C., Jovin, T. M., Westhof, E. and Eckstein, F. (1994) A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. Science 266: 785-788.
140. Uhlenbeck, O. C. (1987) A small catalytic oligoribonucleotide. Nature (Lond.) 328: 596-600.
141. van Tol, H., Buzayan, J. M., Feldstein, P. A., Eckstein, F. and Bruening, G. (1990) Two autolytic processing reactions of a satellite RNA proceed with inversion of configuration. Nucl. Acids Res. 18: 1971-1975.
142. Versnel, M. A., Hagemeijer, A., Bouts, M. J., van der Kwast, T. H. and Hoogesteden, H. C. (1988) Expression of c-sis (PDGF-B chain) and PDGF-A chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene 2: 601-605.
143. Versnel, M. A., Claesson-Welsh, L., Hammacher, A., Bouts, M. J., van der Kwast, T. H., Eriksson, A., Willemsen, R., Weima, S. M., Hoogesteden, H. C., Hagemeijer, A. and Heldin, C.-H. (1991) Human malignant mesothelioma cell lines express PDGF-beta receptors whereas cultured normal mesothelioma cells express predominately PDGF-alpha receptors. Oncogene 6: 2005-2011.
144. Walder, R. W. and Walder, J. A. (1988) Role of RNase H in hybrid arrested translation by antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 85: 5011-5015.
145. Walker, I., Irwin, W. J. and Akhtar, S. (1995) Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates. Pharm. Res. 12: 1548-1553.
146. Wang, K.-S., Choo, Q.-L., Weiner, A. J., Ou, J.-H., Najarian, R. C., Thayer, R. M., Mullenbach, G. T., Denninston, K. J., Gerin, J. L. and Houghton, M. (1986) Structure, sequence and expression of the hepatitis delta (d) viral genome. Nature (Lond.) 323: 508-514. Corrigendum: Nature (Lond.) 328: 456.
147. Wang, K.-S., Choo, Q.-L., Weiner, A. J., Ou, J.-H., Najarian, R. C., Thayer, R. M., Mullenbach, G. T., Denninston, K. J., Gerin, J. L. and Houghton, M. (1986) Structure, sequence and expression of the hepatitis delta (d) viral genome. Nature (Lond.) 323: 508-514. Corrigendum: Nature (Lond.) 328: 456.
148. Werness, B. A., Levine, A. J. and Howley, P. M. (1990) Association of human papillomavirus type 16 and 18 E6 protein with P53. Science 248: 76-79.
149. Whitesell, L., Rosolen, A. and Neckers, L. M. (1991) In vivo modulation of N-myc expression by continuous perfusion with an antisense oligonucleotide. Antisense Res. Dev. 1: 343-350.
150. Wickstrom, E. L., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H. and Wickstrom, E. (1988) Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA 85: 1028-1032.
151. Wickstrom, E., Bacon, T. A. and Wickstrom, E. L. (1992) Down-regulation of c-MYC antigen expression in lymphocytes of Eμ,-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. Cancer Res. 52: 6741-6745.
152. Wicz, J., Sun, D., Klotman, M., Agrawal, S., Zamecnik, P. and Gallo, R. (1992) Specific inhibition of human immunodeficiency virus type 1 replication by anti-sense oligonucleotides: an in vitro model for treatment. Proc. Natl. Acad. Sci. USA 89: 11209-11213.
153. Wny, G. Y. and Wu, C. H. (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262: 4429-4432.
154. Wright, L., Wilson, S. B., Milliken, S., Biggs, J. and Kearney, P. (1993) Ribozyme mediated cleavage of the bcr/abl transcription expressed in chronic myeloid leukemia. Exp. Hematol. 21: 1714-1718.
155. Yokoyama, K. and Imamoto, F. (1987) Transcriptional control of endogenous MYC proto-oncogenes by antisense RNA. Proc. Natl. Acad. Sci. USA 84: 7363-7367.
156. Zamecnik, P. C. and Stephenson, M. L. (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75: 280-284.
157. Zamecnik, P. C., Goodchild, J., Taguchi, Y. and Sarin, P. S. (1986) Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc. Natl. Acad. Sci. USA 83: 4143-4146.